The Therapeutic Potential of Aprepitant in Glioblastoma Cancer Cells through Redox Modification

<div>The anticancer effect of aprepitant on glioblastoma cells. The results of the MTT assay showed that aprepitant could remarkably reduce the viability of U87 cells with an estimated IC50 value of 36.15 <i>μ</i>M.</div>

BioMed Research International

fig1

Figure 1

Figure 1: The Therapeutic Potential of Aprepitant in Glioblastoma Cancer Cells through Redox Modification 